These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26913395)

  • 1. [Methylation of miR-378 in Chronic Myeloid Leukemia].
    Wu DH; Yang J; Yang L; Wen XM; Guo H; Yao DM; Lin J; Zhang YY; Zhang M; Deng ZQ; Qian J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):61-5. PubMed ID: 26913395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Study of SCIN Expression and Dromoter Methylation in Patients with Chronic Myeloid Leukemia].
    Zhang ZH; Lian XY; Li XX; He PF; Lin J; Qian J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):646-651. PubMed ID: 31204912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation status of DDIT3 gene in chronic myeloid leukemia.
    Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
    J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].
    Wang XR; Kang HY; Cen J; Li YH; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1402-4. PubMed ID: 21176338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
    Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
    J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPX3 promoter is methylated in chronic myeloid leukemia.
    Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J
    Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
    Wu DL; Wang Y; Zhang TJ; Chu MQ; Xu ZJ; Yuan Q; Ma JC; Lin J; Qian J; Zhou JD
    Eur J Med Res; 2022 Nov; 27(1):259. PubMed ID: 36411451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and Clinical Significance of DNMT in Patients with Chronic Myeloid Leukemia].
    Li YH; Liu XD; Guo XF; Liu X; Luo JM; Zhang YX; Li ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1547-50. PubMed ID: 26708868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia.
    Chen Q; Lin J; Qian J; Deng ZQ; Qian W; Yang J; Li Y; Chen XX; Ma YJ; Ma JC; Liu Q
    Genet Test Mol Biomarkers; 2013 Jun; 17(6):508-11. PubMed ID: 23495895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SHP-1 gene in the disease progression of chronic myeloid leukemia].
    Li Y; Wang X; Yang L; Pan Y; Shang Y; Luo J
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1074-8. PubMed ID: 25543700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
    Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
    Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34
    Maupetit-Mehouas S; Court F; Bourgne C; Guerci-Bresler A; Cony-Makhoul P; Johnson H; Etienne G; Rousselot P; Guyotat D; Janel A; Hermet E; Saugues S; Berger J; Arnaud P; Berger MG
    Mol Oncol; 2018 Jun; 12(6):814-829. PubMed ID: 29575763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
    Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
    Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
    Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
    Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
    Annamaneni S; Kagita S; Gorre M; Digumarti RR; Satti V; Battini MR
    Hematology; 2014 Jan; 19(1):42-4. PubMed ID: 23541085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis.
    Liu Y; Zheng W; Song Y; Ma W; Yin H
    PLoS One; 2013; 8(7):e68442. PubMed ID: 23894305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
    Ferri C; Bianchini M; Bengió R; Larripa I
    Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.